Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
PaperCitations, authors & open-access status
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 722 citations, 2002 year and closed oa status.
722
Citations
2002
Year
closed
OA Status